Cart
sales@molnova.com
FLT3-IN-10
CAS No. 2088735-51-5
FLT3-IN-10( 2-Oxazolamine, 5-(4-fluorophenyl)-N-phenyl-5-(4-fluorophenyl)-N-phenyl-1,3-oxazol-2-amine )
Catalog No. M28938 CAS No. 2088735-51-5
FLT3-IN-10 (compound 7c) is a potent inhibitor of FMS-like tyrosine kinase 3 (FLT3). FLT3-IN-10 shows the potential for the treatment of FLT3-mutated acute myeloid leukemia (AML).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 49 | In Stock |
|
| 2MG | 30 | In Stock |
|
| 5MG | 51 | In Stock |
|
| 10MG | 88 | In Stock |
|
| 25MG | 181 | In Stock |
|
| 50MG | 262 | In Stock |
|
| 100MG | 373 | In Stock |
|
| 200MG | 507 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameFLT3-IN-10
-
NoteResearch use only, not for human use.
-
Brief DescriptionFLT3-IN-10 (compound 7c) is a potent inhibitor of FMS-like tyrosine kinase 3 (FLT3). FLT3-IN-10 shows the potential for the treatment of FLT3-mutated acute myeloid leukemia (AML).
-
DescriptionFLT3-IN-10 (compound 7c) is a potent inhibitor of FMS-like tyrosine kinase 3 (FLT3). FLT3-IN-10 shows the potential for the treatment of FLT3-mutated acute myeloid leukemia (AML).
-
In Vitro——
-
In Vivo——
-
Synonyms2-Oxazolamine, 5-(4-fluorophenyl)-N-phenyl-5-(4-fluorophenyl)-N-phenyl-1,3-oxazol-2-amine
-
PathwayAngiogenesis
-
TargetFLT
-
Recptorneuropeptide Y (NPY) Y1 receptor
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2088735-51-5
-
Formula Weight254.26
-
Molecular FormulaC15H11FN2O
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 125 mg/mL (491.62 mM)
-
SMILESFC=1C=CC(=CC1)C=2OC(=NC2)NC=3C=CC=CC3
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Antal-Zimanyi I, et al. Pharmacological characterization and appetite suppressive properties of BMS-193885, a novel and selective neuropeptide Y(1) receptor antagonist. Eur J Pharmacol. 2008 Aug 20;590(1-3):224-32.
molnova catalog
related products
-
BGB-102
BGB-102 (JNJ-26483327) is a kinase inhibitor targeting FLT3 and YES1 and an antagonist targeting EGFR and VEGFR3, which may be useful in the study of macular degeneration and diseases associated with genetic disorders and malformations.
-
FLT3-IN-1
FLT3-IN-1 is a novel potent and selective Flt3 inhibitor with IC50 of 10 nM; against FLT3-ITD-expressing MV4-11 cells with IC50 of 6 nM.
-
HM43239 B
HM43239 is an orally active and selective FLT3 inhibitor with IC 50 s of 1.1 nM, 1.8 nM and 1.0 nM for FLT3 WT, FLT3 internal tandem duplication (ITD) and FLT3 D835Y kinases, respectively.
